These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 14523790)

  • 1. Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group.
    Doroshow JH; Synold TW; Gandara D; Mani S; Remick SC; Mulkerin D; Hamilton A; Sharma S; Ramanathan RK; Lenz HJ; Graham M; Longmate J; Takimoto CH; Ivy P
    Semin Oncol; 2003 Aug; 30(4 Suppl 15):14-9. PubMed ID: 14523790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study.
    Ramalingam SS; Kummar S; Sarantopoulos J; Shibata S; LoRusso P; Yerk M; Holleran J; Lin Y; Beumer JH; Harvey RD; Ivy SP; Belani CP; Egorin MJ
    J Clin Oncol; 2010 Oct; 28(29):4507-12. PubMed ID: 20837947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxaliplatin-DNA adduct formation in white blood cells of cancer patients.
    Pieck AC; Drescher A; Wiesmann KG; Messerschmidt J; Weber G; Strumberg D; Hilger RA; Scheulen ME; Jaehde U
    Br J Cancer; 2008 Jun; 98(12):1959-65. PubMed ID: 18506148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?
    Fountzilas C; Stuart S; Hernandez B; Bowhay-Carnes E; Michalek J; Sarantopoulos J; Karnad A; Patel S; Weitman S; Mahalingam D
    Invest New Drugs; 2017 Jun; 35(3):386-391. PubMed ID: 28102465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping the metabolic responses to oxaliplatin-based chemotherapy with
    Olkowicz M; Ramadan K; Rosales-Solano H; Yu M; Wang A; Cypel M; Pawliszyn J
    J Pharm Anal; 2024 Feb; 14(2):196-210. PubMed ID: 38464782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination therapy with oxaliplatin and 5-fluorouracil in a patient with severe hepatic dysfunction associated with metastatic adenocarcinoma of the large bowel.
    Grenader T; Goldberg A; Gabizon A
    Anticancer Drugs; 2009 Oct; 20(9):845-7. PubMed ID: 19633535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group study.
    Synold TW; Takimoto CH; Doroshow JH; Gandara D; Mani S; Remick SC; Mulkerin DL; Hamilton A; Sharma S; Ramanathan RK; Lenz HJ; Graham M; Longmate J; Kaufman BM; Ivy P;
    Clin Cancer Res; 2007 Jun; 13(12):3660-6. PubMed ID: 17575231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunction.
    Baur M; Drescher A; Gneist M; Dittrich C; Jaehde U
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):97-104. PubMed ID: 17396265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLOX (5-fluorouracil + leucovorin + oxaliplatin) chemotherapy for colorectal cancer leads to long-term orofacial neurotoxicity: a STROBE-guided longitudinal prospective study.
    de Albuquerque Ribeiro Gondinho P; de Barros Silva PG; Lisboa MRP; Costa BA; da Rocha Filho DR; Gifoni MAC; Lima MVA; Junior RCPL; Vale ML
    Int J Clin Oncol; 2020 Dec; 25(12):2066-2074. PubMed ID: 32761281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safe use of capecitabine-cisplatin in metastatic gastric carcinoma with severe liver dysfunction: a case report from Algeria.
    Meryem L; Soumia G; Bouchra B
    Electron Physician; 2017 Aug; 9(8):4942-4945. PubMed ID: 28979726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer.
    Garrett MJ; Waddell JA; Solimando DA
    Hosp Pharm; 2017 May; 52(5):341-347. PubMed ID: 28804149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of the oxaliplatin-based chemotherapy in the treatment of advanced primary hepatocellular carcinoma: A meta-analysis of prospective studies.
    Liu L; Zheng YH; Han L; Qin SK
    Medicine (Baltimore); 2016 Oct; 95(40):e4993. PubMed ID: 27749557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Hepatic Impairment on Outcomes in Phase I Clinical Trials in Cancer Subjects.
    Mansfield AS; Rudek MA; Vulih D; Smith GL; Harris PJ; Ivy SP;
    Clin Cancer Res; 2016 Nov; 22(22):5472-5479. PubMed ID: 27189163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatotoxicity Secondary to Chemotherapy.
    Grigorian A; O'Brien CB
    J Clin Transl Hepatol; 2014 Jun; 2(2):95-102. PubMed ID: 26357620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer.
    Kasi PM; Thanarajasingam G; Finnes HD; Villasboas Bisneto JC; Hubbard JM; Grothey A
    Case Rep Oncol Med; 2015; 2015():420159. PubMed ID: 26090248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical management of inflammatory bowel disease in the organ recipient.
    Indriolo A; Ravelli P
    World J Gastroenterol; 2014 Apr; 20(13):3525-33. PubMed ID: 24707135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gefitinib, Fluorouracil, Oxaliplatin, and Leucovorin (IFOX) Regimen for Colorectal Cancer.
    Chen AS; Solimando DA; Waddell JA
    Hosp Pharm; 2013 Dec; 48(11):905-11. PubMed ID: 24474830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful and well-tolerated second line therapy with cetuximab, irinotecan, and raltitrexed in progressive liver disease due to metastatic colon cancer.
    Geurs F; Vandewaeter S; Ponette S; Ponette J; Knape S; Demetter P
    J Gastrointest Cancer; 2008; 39(1-4):26-8. PubMed ID: 19418267
    [No Abstract]   [Full Text] [Related]  

  • 19. Incidence and management of colorectal cancer in liver transplant recipients.
    Nishihori T; Strazzabosco M; Saif MW
    Clin Colorectal Cancer; 2008 Jul; 7(4):260-6. PubMed ID: 18650194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of cancer therapies in older adults.
    Hurria A; Lichtman SM
    Br J Cancer; 2008 Feb; 98(3):517-22. PubMed ID: 18256586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.